Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Bug factories for drugs: quality control holds key to quantity

Society For General Microbiology : 08 September, 2004  (Company News)
Tiny types of soil bugs already make many of the products we use in washing detergents, foods, and waste treatment, but scientists now hope that similar bacteria will also make the vaccines and drugs of the future, according to new research presented at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
Researchers from the Institute of Cell and Molecular Studies at Newcastle University have successfully produced small quantities of a promising new vaccine for anthrax using Bacillus bacteria which have been modified to produce human medicines.

'Many people already use enzymes produced by these bacteria to wash their clothes,' says Professor Colin Harwood of Newcastle University. 'But the bacteria which make these enzymes, so useful for digesting dirt, have very efficient quality control systems which spot rogue proteins and enzymes and destroy them. This control mechanism stops us using these bacteria to make large quantities of the pure proteins we need for use in vaccines and other medicines.'

The scientists have spent the last ten years, working with a Europe-wide group of 11 research laboratories, discovering how bacteria move enzymes and proteins from inside their cells, where they are made, to the outside world, where they are needed.

An important component of the system for moving proteins across the cell membrane turns out to be a quality control mechanism which recognises and breaks down foreign proteins. The bacteria need this checking mechanism to survive in competitive natural environments such as the soil. But this same checking system means that any drug production is disappointingly low if we try to use the bacteria to make useful medicines.

'Bacilli could make authentic versions of some of the important proteins we have identified from the results of the Human Genome Project, at concentrations of 20 grammes per litre - which is commercially acceptable,' says Prof Harwood. 'These bacteria are wonderfully efficient factories, and using them would reduce purification costs and provide structurally authentic proteins.'

'A better understanding of bacteria will allow us to produce human and animal medicines,' says Prof Harwood. 'However, since the protein secretion apparatus and quality control systems are also essential for the bacteria's survival, they also give us new targets for antibiotic drugs.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo